Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Steel

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
BMC Geriatrics|October 23, 2019
Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort studyCarlota M Grossi, Kathryn Richardson, Chris Fox, et al.
Journal of Alzheimer'S Disease : JAD|March 3, 2020
Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug UseKathryn Richardson, Stephen B Wharton, Carlota M Grossi, et al.
American Journal of Epidemiology|May 22, 2019
History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control StudyKathryn Richardson, Katharina Mattishent, Yoon K Loke, et al.
BMJ (Clinical Research Ed.)|April 27, 2018
Anticholinergic drugs and risk of dementia: case-control studyKathryn Richardson, Chris Fox, Ian Maidment, et al.
Age and Ageing|July 1, 2020
Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysisNina T Pieper, Carlota M Grossi, Wei-Yee Chan, et al.
Lancet (London, England)|December 1, 2018
Changes in health in the countries of the UK and 150 English Local Authority areas 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016Nicholas Steel, John A Ford, John N Newton, et al.
The Lancet Regional Health. Europe|April 8, 2022
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990-2019: Findings from the Global Burden of Disease Study 2019Giulio Castelpietra, Ann Kristin Skrindo Knudsen, Emilie E Agardh, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
BMC Geriatrics|October 23, 2019
Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort studyCarlota M Grossi, Kathryn Richardson, Chris Fox, et al.
Journal of Alzheimer'S Disease : JAD|March 3, 2020
Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug UseKathryn Richardson, Stephen B Wharton, Carlota M Grossi, et al.
American Journal of Epidemiology|May 22, 2019
History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control StudyKathryn Richardson, Katharina Mattishent, Yoon K Loke, et al.
BMJ (Clinical Research Ed.)|April 27, 2018
Anticholinergic drugs and risk of dementia: case-control studyKathryn Richardson, Chris Fox, Ian Maidment, et al.
Age and Ageing|July 1, 2020
Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysisNina T Pieper, Carlota M Grossi, Wei-Yee Chan, et al.
Lancet (London, England)|December 1, 2018
Changes in health in the countries of the UK and 150 English Local Authority areas 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016Nicholas Steel, John A Ford, John N Newton, et al.
The Lancet Regional Health. Europe|April 8, 2022
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990-2019: Findings from the Global Burden of Disease Study 2019Giulio Castelpietra, Ann Kristin Skrindo Knudsen, Emilie E Agardh, et al.
Pageof 6